Prostate Cancer
Serum testosterone level, testosterone replacement treatment, and prostate cancer - Abstract
November 21, 2013
State of the art in nuclear imaging for the diagnosis of bone metastases - Abstract
November 21, 2013
Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancer - Abstract
November 21, 2013
Racial and socioeconomic disparities in the selection of prostate brachytherapy - Abstract
November 21, 2013
Risk of biochemical recurrence and positive surgical margins in patients with pT2 prostate cancer undergoing radical prostatectomy - Abstract
November 21, 2013
Sedentarism and overweight as risk factors for the detection of prostate cancer and its aggressivenes - Abstract
November 21, 2013
Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen - Abstract
November 21, 2013
Safety and antitumor efficacy of 153Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer - Abstract
November 21, 2013
Holmium laser enucleation of the prostate is safe in patients with prostate cancer and lower urinary tract symptoms - A retrospective feasibility study - Abstract
November 19, 2013
Ureteral injuries sustained during robotic assisted laparoscopic prostatectomy - Abstract
November 19, 2013
Dosimetric effects of prone and supine positions on post-implant assessments for prostate brachytherapy - Abstract
November 19, 2013
Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy - Abstract
November 19, 2013
Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: Correlation with Gleason score of prostate cancer - Abstract
November 19, 2013